Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129357350> ?p ?o ?g. }
- W2129357350 endingPage "6377" @default.
- W2129357350 startingPage "6368" @default.
- W2129357350 abstract "The discovery of aurora kinases as essential regulators of cell division has led to intense interest in identifying small molecule aurora kinase inhibitors for the potential treatment of cancer. A high-throughput screening effort identified pyridinyl-pyrimidine 6a as a moderately potent dual inhibitor of aurora kinases -A and -B. Optimization of this hit resulted in an anthranilamide lead (6j) that possessed improved enzyme and cellular activity and exhibited a high level of kinase selectivity. However, this anthranilamide and subsequent analogues suffered from a lack of oral bioavailability. Converting the internally hydrogen-bonded six-membered pseudo-ring of the anthranilamide to a phthalazine (8a−b) led to a dramatic improvement in oral bioavailability (38−61%F) while maintaining the potency and selectivity characteristics of the anthranilamide series. In a COLO 205 tumor pharmacodynamic assay measuring phosphorylation of the aurora-B substrate histone H3 at serine 10 (p-histone H3), oral administration of 8b at 50 mg/kg demonstrated significant reduction in tumor p-histone H3 for at least 6 h." @default.
- W2129357350 created "2016-06-24" @default.
- W2129357350 creator A5000194483 @default.
- W2129357350 creator A5001620453 @default.
- W2129357350 creator A5006564262 @default.
- W2129357350 creator A5007920990 @default.
- W2129357350 creator A5010612613 @default.
- W2129357350 creator A5012789782 @default.
- W2129357350 creator A5014135121 @default.
- W2129357350 creator A5014586497 @default.
- W2129357350 creator A5016041738 @default.
- W2129357350 creator A5018271028 @default.
- W2129357350 creator A5019012715 @default.
- W2129357350 creator A5024440471 @default.
- W2129357350 creator A5025120206 @default.
- W2129357350 creator A5026546767 @default.
- W2129357350 creator A5029922980 @default.
- W2129357350 creator A5033216492 @default.
- W2129357350 creator A5033217111 @default.
- W2129357350 creator A5035229359 @default.
- W2129357350 creator A5048268356 @default.
- W2129357350 creator A5050730829 @default.
- W2129357350 creator A5053383296 @default.
- W2129357350 creator A5053499853 @default.
- W2129357350 creator A5053917680 @default.
- W2129357350 creator A5060179060 @default.
- W2129357350 creator A5070809892 @default.
- W2129357350 creator A5075759442 @default.
- W2129357350 creator A5078718914 @default.
- W2129357350 creator A5078787495 @default.
- W2129357350 creator A5083026456 @default.
- W2129357350 creator A5089786433 @default.
- W2129357350 creator A5091908601 @default.
- W2129357350 date "2010-08-04" @default.
- W2129357350 modified "2023-10-07" @default.
- W2129357350 title "Discovery of a Potent, Selective, and Orally Bioavailable Pyridinyl-Pyrimidine Phthalazine Aurora Kinase Inhibitor" @default.
- W2129357350 cites W1556655356 @default.
- W2129357350 cites W1568426705 @default.
- W2129357350 cites W1979308791 @default.
- W2129357350 cites W1980577287 @default.
- W2129357350 cites W2007578216 @default.
- W2129357350 cites W2007938871 @default.
- W2129357350 cites W2013928497 @default.
- W2129357350 cites W2016462887 @default.
- W2129357350 cites W2020160932 @default.
- W2129357350 cites W2020293198 @default.
- W2129357350 cites W2029335488 @default.
- W2129357350 cites W2029821163 @default.
- W2129357350 cites W2049885874 @default.
- W2129357350 cites W2058422185 @default.
- W2129357350 cites W2064261028 @default.
- W2129357350 cites W2068359234 @default.
- W2129357350 cites W2071156666 @default.
- W2129357350 cites W2071500926 @default.
- W2129357350 cites W2074974381 @default.
- W2129357350 cites W2079398727 @default.
- W2129357350 cites W2084217607 @default.
- W2129357350 cites W2085036739 @default.
- W2129357350 cites W2098517908 @default.
- W2129357350 cites W2099637764 @default.
- W2129357350 cites W2101635775 @default.
- W2129357350 cites W2127896256 @default.
- W2129357350 cites W2137429755 @default.
- W2129357350 cites W2137898468 @default.
- W2129357350 cites W2140557275 @default.
- W2129357350 cites W2140760855 @default.
- W2129357350 cites W2148649353 @default.
- W2129357350 cites W2156972915 @default.
- W2129357350 cites W2168300715 @default.
- W2129357350 doi "https://doi.org/10.1021/jm100394y" @default.
- W2129357350 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20684549" @default.
- W2129357350 hasPublicationYear "2010" @default.
- W2129357350 type Work @default.
- W2129357350 sameAs 2129357350 @default.
- W2129357350 citedByCount "31" @default.
- W2129357350 countsByYear W21293573502012 @default.
- W2129357350 countsByYear W21293573502013 @default.
- W2129357350 countsByYear W21293573502014 @default.
- W2129357350 countsByYear W21293573502015 @default.
- W2129357350 countsByYear W21293573502016 @default.
- W2129357350 countsByYear W21293573502018 @default.
- W2129357350 countsByYear W21293573502020 @default.
- W2129357350 countsByYear W21293573502021 @default.
- W2129357350 countsByYear W21293573502022 @default.
- W2129357350 crossrefType "journal-article" @default.
- W2129357350 hasAuthorship W2129357350A5000194483 @default.
- W2129357350 hasAuthorship W2129357350A5001620453 @default.
- W2129357350 hasAuthorship W2129357350A5006564262 @default.
- W2129357350 hasAuthorship W2129357350A5007920990 @default.
- W2129357350 hasAuthorship W2129357350A5010612613 @default.
- W2129357350 hasAuthorship W2129357350A5012789782 @default.
- W2129357350 hasAuthorship W2129357350A5014135121 @default.
- W2129357350 hasAuthorship W2129357350A5014586497 @default.
- W2129357350 hasAuthorship W2129357350A5016041738 @default.
- W2129357350 hasAuthorship W2129357350A5018271028 @default.
- W2129357350 hasAuthorship W2129357350A5019012715 @default.
- W2129357350 hasAuthorship W2129357350A5024440471 @default.
- W2129357350 hasAuthorship W2129357350A5025120206 @default.